Editorial
Counteracting aldosterone in cardiorenal disease in type 2 diabetes through finerenone administration
Contrarrestar la aldosterona en la enfermedad cardiorrenal en la diabetes tipo 2 mediante la administración de finerenona
Read
601
Timeswas read the article
22
Total PDF
579
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 December | 5 | 0 | 5 |
| 2024 November | 17 | 0 | 17 |
| 2024 October | 15 | 0 | 15 |
| 2024 September | 41 | 3 | 44 |
| 2024 August | 29 | 0 | 29 |
| 2024 July | 21 | 4 | 25 |
| 2024 June | 24 | 2 | 26 |
| 2024 May | 35 | 0 | 35 |
| 2024 April | 40 | 0 | 40 |
| 2024 March | 46 | 0 | 46 |
| 2024 February | 31 | 0 | 31 |
| 2024 January | 28 | 0 | 28 |
| 2023 December | 186 | 2 | 188 |
| 2023 November | 4 | 0 | 4 |
| 2023 September | 3 | 2 | 5 |
| 2023 August | 2 | 1 | 3 |
| 2023 July | 4 | 0 | 4 |
| 2023 June | 1 | 0 | 1 |
| 2023 May | 46 | 2 | 48 |
| 2023 April | 1 | 0 | 1 |
| 2023 February | 0 | 4 | 4 |
| 2023 January | 0 | 2 | 2 |
Show all